Results 121 to 130 of about 9,302 (232)
Supplemental material, sj-docx-1-cms-10.1177_12034754241239269 for Retinoids and Risk: A FAERS Database Study of Topical Retinoids by Simona A. Alomary, Mingzhuo Pei and Shari R.
Shari R. Lipner (7524403) +2 more
core +1 more source
Triptorelin associated adverse events evaluated using FAERS pharmacovigilance data
Triptorelin, a gonadotropin-releasing hormone(GnRH) agonist, is approved by the US Food and Drug Administration(FDA) for treating advanced prostate cancer, endometriosis, and central precocious puberty(CPP) in children aged ≥ 2 years. This study aimed to
Tiezhou Wang, Wei Jia
core +1 more source
Background: Sevoflurane, an ether-derived inhalational anesthetic widely used for general anesthesia, requires comprehensive safety evaluation. Objectives: This study aimed to identify sevoflurane-associated adverse events and detect unexpected safety ...
core +1 more source
, 2015 From a drug safety standpoint, post-marketing data analysis is a valuable tool for gaining insight into adverse drug reactions (ADRs). However, analyzing post-marketing data without the appropriate precautions may result in the omission of crucial drug ...
Lounkine, Eugen +5 more
core
Agent-Specific Clinical Profiles of Antibiotic-Associated Encephalopathy: A Dual-Database Pharmacovigilance Study Using JADER and FAERS. [PDF]
Antibiotics (Basel)Itagaki H.
europepmc +1 more source
Global patterns and trends in spontaneous reporting systems: VigiBase, FAERS, VAERS, and JADER. [PDF]
Front Drug Saf RegulPanajotovikj N, Mestres J.
europepmc +1 more source
Musculoskeletal Adverse Event Signals Associated With Semaglutide, Liraglutide, and Tirzepatide in the US FDA Adverse Event Reporting System. [PDF]
CureusWadhwa A +4 more
europepmc +1 more source
Multinational pharmacovigilance assessment of drug-associated esophageal ulceration and perforation: evidence from FAERS, JADER, and Canada Vigilance. [PDF]
BMC Pharmacol ToxicolZhang L +6 more
europepmc +1 more source